Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Insulin secretion and beta-cell function represents a complex physiological process centered in the pancreatic islets of Langerhans, where specialized beta cells produce and release insulin in response to blood glucose levels[2][3]. Beta cells constitute approximately 50-70% of human islet cells and serve as sophisticated nutrient sensors that primarily detect glucose, but also respond to amino acids and fatty acids[2][3].\n\nThe triggering pathway of glucose-stimulated insulin secretion begins when glucose enters beta cells through glucose transporters (primarily GLUT1 and GLUT3 in humans, GLUT2 in rodents)[3]. Glucokinase, which has a Km of 8 mM, catalyzes the rate-limiting first step of glycolysis and sets the threshold for rapid glucose metabolism[2]. As glucose is metabolized through glycolysis and the tricarboxylic acid cycle, cellular ATP levels rise, increasing the ATP/ADP ratio[2][5]. This elevated ATP/ADP ratio causes ATP-sensitive potassium channels (K_ATP channels) to close, leading to membrane depolarization[3][5]. Subsequently, voltage-gated calcium channels open, allowing calcium influx that triggers exocytosis of insulin-containing vesicles[5].\n\nThe process exhibits biphasic kinetics, with a rapid initial phase of insulin release followed by sustained steady-state secretion[5]. Mitochondrial metabolism plays a crucial role by generating both ATP for the triggering pathway and metabolic coupling factors that amplify the insulin secretory response[2]. Anaplerosis, the replenishment of TCA cycle intermediates primarily through pyruvate carboxylase, is essential for sustained insulin secretion[2].\n\nBeta cells demonstrate remarkable adaptive capacity, adjusting their metabolic activity and insulin secretion in response to varying physiological demands such as nutrition, exercise, age, and reproductive state[2]. This adaptation occurs through multiple regulatory mechanisms including allosteric control, covalent modifications, and transcriptional changes in metabolic enzyme expression[2]. Recent research has revealed that beta cells comprise functionally distinct subpopulations with elevated glucokinase activity and metabolic rates that influence overall islet dynamics[6]. These subpopulations synchronize through both their intrinsic metabolic properties and gap junction coupling between cells[6].\n\nThe failure of beta cells to adequately adapt insulin secretion during insulin resistance is a key predictor of progression to type 2 diabetes[2]. Longitudinal studies indicate that impaired compensatory insulin secretion, rather than insulin resistance alone, determines diabetes susceptibility[2]. Age-related decline in beta-cell function, including weakened gap junction coupling and disrupted synchronization, contributes to increased diabetes risk[6]. Understanding the intricate mechanisms controlling beta-cell function remains critical for developing therapeutic strategies to prevent and treat diabetes.
The process involves multiple mechanisms: K_ATP channel closure leading to membrane depolarization; Voltage-gated calcium channel opening; Calcium-triggered insulin granule exocytosis; Metabolic coupling through ATP/ADP ratio changes; Glucokinase-mediated glucose sensing; Mitochondrial metabolism and anaplerosis; Gap junction-mediated beta-cell synchronization
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Insulin secretion and pancreatic beta-cell function (GSIS).